The DOI matches its Crossref record; 8 of the 10 references it cites were found in a registry or an index.
Psychedelic therapy: a roadmap for wider acceptance and utilization
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Mithoefer, M. C. et al. Psychopharmacol. 236, 2735–2745 (2019).”
Cited work 10.1007/s00213-019-05249-5 · retracted 2024-08-10 · notice 10.1007/s00213-024-06666-x · this paper published 2021-10
Citations
Cites
1 retracted
Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., Hamilton, S., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05249-5 · Cited by 359
RetractedGriffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3285 · Cited by 1,301
Agin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360
Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.012 · Cited by 354
Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature.
Michaels, T. I., Purdon, J., Collins, A., & Williams, M. T. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1824-6 · Cited by 265
Harm potential of magic mushroom use: A review
Amsterdam, J. V., Opperhuizen, A., & Brink, W. V. D. (2011) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2011.01.006 · Cited by 208
Psilocybin for treating substance use disorders?
de Veen, B. T. H., Schellekens, A., Verheij, M. M. M., & Homberg, J. R. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1220834 · Cited by 118
Research works printed but not linked: 5
- Marks, M. N. Y. Univ. J. Legis. Public Policy 21, 69–140 (2018).
- Marks, M. M. Adm. Law Rev. 72, 649–718 (2020).
- McCall, B. Nat. Med. https://www.nature.com/articles/d41591-020-00001-5 (2020).
- Richert, L. Psychology Today https://www.psychologytoday.com/us/blog/hygieias-workshop/202107/the-complicated-patenting-our-psychedelic-future (2021).
- Schreck, M. MAPS Bulletin 21, 26–28 (2011).
Cited by
Default Mode Network Modulation by Psychedelics: A Systematic Review
Gattuso, J. J., Perkins, D., Ruffell, S., Lawrence, A. J., Hoyer, D., Jacobson, L. H., Timmermann, C., Castle, D., Rossell, S. L., Downey, L. A., et al. (2023) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac074 · Cited by 256
Aday, J. S., Heifets, B. D., Pratscher, S. D., Bradley, E., Rosen, R., & Woolley, J. D. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06123-7 · Cited by 237
Psychedelic Drug Legislative Reform and Legalization in the US
Siegel, J. S., Daily, J. E., Perry, D. A., & Nicol, G. E. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.4101 · Cited by 179
Novel ethical and policy issues in psychiatric uses of psychedelic substances
Smith, W., & Appelbaum, P. S. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109165 · Cited by 72
The varieties of psychedelic law
Marks, M. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109399 · Cited by 73
Self-citation
Metadata
- Authors
- Marks, M., & Cohen, I. G.
- Affiliations
- Harvard University (US)
- Corresponding author
- Marks, Mason
- Venue
- Nature Medicine
- Published
- 2021-10
- Volume
- 27
- Issue
- 10
- Pages
- 1669-1671
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W3203095924
- Semantic Scholar
- a57107d9bc67582570f7966ddc0253cadf377b15
- Cited by
- 59
- References
- 10
- Citations by year
- 2026: 2 · 2025: 12 · 2024: 16 · 2023: 14 · 2022: 13 · 2021: 2
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- The author receives funding from POPLAR, which is financially supported by the Saisei Foundation, a non-profit organization based in Austin, Texas.
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psychedelic therapy, psychedelics, psychotherapy, drug regulation, legal barriers
- MeSH terms
- Legal Epidemiology, Mental Disorders, Hallucinogens, Humans, Mental Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychedelic therapy: a roadmap for wider acceptance and utilization. https://app.cochat.ai/papers/10.1038/s41591-021-01530-3
- The paper
- Marks, M., & Cohen, I. G. (2021). Psychedelic therapy: a roadmap for wider acceptance and utilization. Nature Medicine. https://doi.org/10.1038/s41591-021-01530-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.